Vol. 5 (02) pp. 725-733 DOI: 10.21474/IJAR01/3208

PHARMACOKINETICS OF BIO-THERAPEUTICS: Rituximab

18 Downloads 119 Views
Crossref

Download Full Paper (PDF)

Keywords

How to Cite This Article

Parbhat Saini. (2017); PHARMACOKINETICS OF BIO-THERAPEUTICS: Rituximab, International Journal of Advanced Research (IJAR), 5 (02), 725-733, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/3208

Corresponding Author

Parbhat Saini
Birla Institute of Technology and Science,PIlani,Rajasthan

Article Analytics

References

  1. JoséeGolay, GianpietroSemenzato, Alessandro Rambaldi, Robin FoàGianlucaGaidano, (2013) Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics, mAbs, 5:6, 826-837, DOI: 10.4161/mabs.26008
  2. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG. Mapping of the C1q binding site on rituxan, a chimericantibody with a human IgG1 Fc. J Immunol2000; 164:4178-84; PMID:10754313
  3. Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetic and pharmacodynamics. J Pharm Sci 2004; 93:2645-68; PMID:15389672; http://dx.doi. org/10.1002/jps.20178
  4. Kagan L, Turner MR, Balu-Iyer SV, Mager DE. Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in rats. Pharm Res 2012; 29:490-9; PMID:21887597; http://dx.doi. org/10.1007/s11095-011-0578-3.
 

Similar Articles

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.